Table 1.
Baseline characteristics of the older patients with diminished ovarian reserve (POSEIDIN group 4) treated with or without DHEA.
| Parameters | DHEA | Non-DHEA | p-value |
|---|---|---|---|
| (n = 159) | (n = 138) | ||
| Age (years) | 39.8 ± 2.5 | 40.2 ± 2.9 | 0.295 |
| Body mass index (kg/m2) | 22.3 ± 3.1 | 23.0 ± 3.7 | 0.054 |
| Infertility duration (years) | 5.6 ± 4.6 | 4.9 ± 4.3 | 0.177 |
| Previous IVF attempts (n) | 2.5 ± 2.7 | 1.3 ± 1.6 | < 0.001 |
| Types of infertility (%) | 0.166 | ||
| Primary infertility | 43.4 | 51.4 | |
| Secondary infertility | 56.6 | 48.6 | |
| Basal FSH (IU/l) | 7.3 ± 4.5 | 6.3 ± 4.1 | 0.082 |
| Antral follicle counts (n) | 4.5 ± 2.4 | 4.2 ± 2.3 | 0.342 |
| Anti-Müllerian hormone (ng/ml) | 0.5 ± 0.3 | 0.7 ± 0.3 | 0.003 |
Data are presented as mean ± standard deviation or %.
DHEA, dehydroepiandrosterone; IVF, in vitro fertilization; FSH, follicle stimulation hormone.